Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Nov 2024: Trump’s HHS pick drags down jab makers’ stocks; Novartis, Merck, Roche ink billion-dollar deals

    Stock Recap
    #PipelineProspector

    Menu

    Nafronyl Oxalate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Procos
    Italy
    		 Sungjin Exim Co., Ltd. 20210323-211-J-895 Naphronyl oxalate 2021-03-23 Procos SPA Italy Viamatteotti 249, Cameri(Novara)28062 Italy
    28/09/2024 Procos
    Italy
    		 Ace Biopharm Co., Ltd. 20210323-211-J-895(1) Naphronyl oxalate 2021-05-18 Procos SPA Italy Viamatteotti 249, Cameri(Novara)28062 Italy